Cancer Research The Future of Cancer Research: Science and Patient Impact  Tumor Immunology: New Perspectives
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Cancer Research Clinical Cancer Research
Cancer Epidemiology Biomarkers & Prevention Molecular Cancer Therapeutics
Molecular Cancer Research Cancer Prevention Research
Cancer Prevention Journals Portal Cancer Reviews Online
Annual Meeting Education Book Meeting Abstracts Online

[Cancer Research 27, 1779-1782, October 1, 1967]
© 1967 American Association for Cancer Research

This Article
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow reprints & permissions
Citing Articles
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Yarbro, J. W.
Right arrow Articles by Kennedy, B. J.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Yarbro, J. W.
Right arrow Articles by Kennedy, B. J.

A Comparison of the Rate of Recovery from Inhibition of RNA Synthesis in Mouse Liver and Transplantable Glioma1

John W. Yarbro and B. J. Kennedy

Department of Medicine, University of Minnesota Medical Center, Minneapolis, Minnesota 55455

In an attempt to reduce the clinical toxicity of mithramycin by an altered dosage regimen, RNA synthesis was studied in an experimental mouse glioma and in mouse liver at varying times following treatment with mithramycin. There was a marked dissociation between the rate of recovery of these two tissues from the RNA-inhibitory effect produced by mithramycin. Whereas liver rapidly recovered its capacity for RNA synthesis, the recovery of the tumor was delayed. This suggested that an alternate-day dosage regimen might reduce toxicity while maintaining antitumor effect. Extension of such a regimen into clinical studies has given promising results.

1 This investigation was supported in part by USPHS Research Grants CA-3143, CA-08344, CA-08832, and CA-05862 from the National Cancer Institute.

Received 2/20/67. Accepted 5/23/67.







HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Cancer Research Clinical Cancer Research
Cancer Epidemiology Biomarkers & Prevention Molecular Cancer Therapeutics
Molecular Cancer Research Cancer Prevention Research
Cancer Prevention Journals Portal Cancer Reviews Online
Annual Meeting Education Book Meeting Abstracts Online
Copyright © 1967 by the American Association for Cancer Research.